secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001079973-24-001502
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q3 2024 net loss $158K, revenue down 23% YoY; SpinDx progress
---------------------------------------------------------------------

- Q3 net revenue $2.087M (down 23% YoY); net loss $158K ($0.06/diluted) vs prior year profit $110K.
- Nine-month 2024 revenue $6.628M, net loss $740K ($0.30/diluted) vs prior year profit $111K.
- Gross margin improved to 43.7% in Q3 vs 41.5% last year; nine-month 41.4% vs 43.4%.
- SpinDx saliva THC detection system beta testing planned this quarter; commercial launch projected later in 2025.
- Raised $750K line of credit and $798K private placement (210K shares at $3.80) to fund SpinDx development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324001502/0001079973-24-001502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324001502/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-001502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer